ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer

Published:2014-03-06 Issue:8 Volume:110 Page:2030-2039
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Shimizu K,Kaira K,Tomizawa Y,Sunaga N,Kawashima O,Oriuchi N,Tominaga H,Nagamori S,Kanai Y,Yamada M,Oyama T,Takeyoshi I

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201488.pdf

Reference27 articles.

1. Altman A, Cardenas JM, Houghten RA, Dixon FJ, Theofilopoulos AN (1984) Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. Proc Natl Acad Sci 81: 2176–2180.

2. Brundage MD, Davies D, Mackillop WJ (2002) Prognostic factors in non-small cell lung cancer: a decade of prognosis. Chest 122: 1037–1057.

3. Chairoungdua A, Kanai Y, Matsuo H, Inatomi J, Kim DK, Endou H (2001) Identification and characterization of a novel member of the heterodimeric amino acid transporter family presumed to be associated with an unknown heavy chain. J Biol Chem 276: 49390–49399.

4. Fuchs BC, Bode BP (2006) Amino acid transporters ASCT2 and LAT1 in cancer: Partners in crime? Semin Cancer Biol 15: 254–266.

5. Fuchs BC, Finger RE, Onan MC, Bode BP (2007) ASCT2 silencing regulates mammalian target of rapamycin growth and survival signaling in human hepatoma cells. Am J Physiol Cell Physiol 293: C55–C63.

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic significance of LAT1 expression in pleural mesothelioma;Heliyon;2024-09

2. The potential therapeutic targets of glutamine metabolism in head and neck squamous cell carcinoma;Biomedicine & Pharmacotherapy;2024-07

3. METTL3-mediated m6A methylation of SLC38A1 stimulates cervical cancer growth;Biochemical and Biophysical Research Communications;2024-07

4. ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study;Targeted Oncology;2024-04-29

5. Progesterone inhibits endometrial cancer growth by inhibiting glutamine metabolism through ASCT2;Bioscience Reports;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3